| All Children's Therapy, Inc | |
|
10201 W Markham St # 216, Little Rock, AR 72205-2195 | |
| (501) 772-7771 | |
| (501) 694-9463 |
| Full Name | All Children's Therapy, Inc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 10201 W Markham St # 216, Little Rock, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003112160 | NPI | - | NPPES |
| 185142742 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| All Children's Therapy, Inc 12410 Cantrell Rd., Suite 200, Little Rock, AR 72223 Ph: (501) 868-1212 | All Children's Therapy, Inc 10201 W Markham St # 216, Little Rock, AR 72205-2195 Ph: (501) 772-7771 |
News Archive
The U.S. Food and Drug Administration today approved Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition) in adult patients, providing a source of calories and essential fatty acids for adult patients who are unable to eat or drink. Clinolipid was granted a priority review to help alleviate a drug shortage.
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, updated preliminary data from an ongoing randomized 110 patient Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
Europe's largest healthy ageing study - DO-HEALTH - which aims to provide evidence for the safety of three simple preventive interventions: vitamin D, omega-3 fatty acids and a simple home exercise programme, has recruited 532 of its target 2,000 seniors.
› Verified 5 days ago
Laura Dickson, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9720 N Rodney Parham Rd, Little Rock, AR 72227 Phone: 501-228-3808 | |
Ms. Marcia Roles Bingham, MS.CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11517 Kanis Rd, Little Rock, AR 72211 Phone: 501-993-8707 Fax: 501-223-8075 | |
Jessica Letzig Berkow, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Aldersgate Rd, Little Rock, AR 72205 Phone: 501-821-6116 | |
Brooke Harris, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3920 Woodland Heights Rd, Little Rock, AR 72212 Phone: 501-227-3600 Fax: 501-227-4021 | |
Mrs. Tracy Bair Pate, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Way, Little Rock, AR 72202 Phone: 501-364-6688 Fax: 501-364-6646 | |
Kaylee Pickle, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1900 Aldersgate Rd, Little Rock, AR 72205 Phone: 501-227-0434 |